List of SBIR/STTR awards granted to Azevan Pharmaceuticals
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Azevan Pharmaceuticals in September, 2020 for $3,190,881.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44NS090616-05 | Phase II | 3,190,881 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to Azevan Pharmaceuticals in May, 2019 for $501,472.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS110343-01A1 | Phase I | 501,472 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Azevan Pharmaceuticals in March, 2016 for $3,329,539.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1U44NS090616-01A1 | Phase I | 3,329,539 | March 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Azevan Pharmaceuticals in March, 2016 for $4,519,924.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4U44NS090616-02 | Phase II | 4,519,924 | March 1, 2016 | |||||||
A STTR Phase II contract was awarded to Azevan Pharmaceuticals for $498,684.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42HD037290-02A1 | Phase II | 498,684 | ||||||||
A SBIR Phase II contract was awarded to Azevan Pharmaceuticals for $226,385.0 USD from the U.S. Department of Health & Human Services. | SBIR | 3R44MH063663-08S1 | Phase II | 226,385 | ||||||||
A STTR Phase I contract was awarded to Azevan Pharmaceuticals from the U.S. Department of Health & Human Services. | STTR | 2R42HD037290-02A1 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Azevan Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41MH063663-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Azevan Pharmaceuticals for $349,195.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44MH087001-01A1 | Phase I | 349,195 | ||||||||
A SBIR Phase II contract was awarded to Azevan Pharmaceuticals for $1,794,075.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MH087001-02 | Phase II | 1,794,075 | ||||||||
A STTR Phase I contract was awarded to Azevan Pharmaceuticals for $141,071.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41MH093049-01A1 | Phase I | 141,071 | ||||||||
A STTR Phase I contract was awarded to Azevan Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services. | STTR | Phase I | 100,000 |
